Welcome
Craig M. Kessler, MD, MACP

Chairman’s Introduction
Craig M. Kessler

Cancer, Thrombosis, and The Pathobiology of Malignancy: A Science-to-Clinical Strategy Perspective-The Role of LMWHs at the Interface of Thrombosis and Cancer
Frederick R. Rickles, MD, FACP

Primary and Secondary Thrombosis Prophylaxis in the Setting of Cancer: Critical Challenges, Identifying Patients at Risk-What Do Landmark Trails Teach Us About Optimizing Patient Care
Craig M. Kessler

The Pharmacologic Foundations of Thrombosis Prophylaxis in the Setting of Cancer: Dosing Issues in Complex Patients and Special Populations
Edith Nutescu, FCCP